CLINICAL IMMUNOBIOCHEMICAL MARKERS IN OPTIMIZING THE DIAGNOSTICS OF BRONCHIAL ASTHMA IN COMORBIDITY WITH TYPE 2 DIABETES MELLITUS
loading.default
item.page.files
item.page.date
item.page.authors
item.page.journal-title
item.page.journal-issn
item.page.volume-title
item.page.publisher
Modern American Journals
item.page.abstract
The relevance of the study is due to the high frequency of bronchial asthma (BA) and type 2 diabetes mellitus (T2DM), which mutually aggravate each other. The aim of the study was to investigate clinical and immunobiochemical markers to optimize the diagnosis and assess the severity of BA combined with T2DM.